Archives

  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • 2-APB (2-aminoethoxydiphenyl borate): IP3R Antagonist Profil

    2026-04-27

    2-APB (2-aminoethoxydiphenyl borate): Precision Antagonist for Calcium Signaling Research

    Executive Summary: 2-APB (2-aminoethoxydiphenyl borate) is a cell-permeable antagonist of inositol 1,4,5-trisphosphate (IP3)-induced calcium release, with an IC50 of 42 μM in rat cerebellar microsomes (source: product_spec). It also inhibits TRPC3, TRPC5 (IC50 = 20 μM, HEK-293 cells), and TRPC6 channels, making it a valuable tool for dissecting store-operated calcium entry (SOCE) (source: workflow_recommendation). 2-APB is widely used to study calcium oscillations and waves, oxidative stress-related cell injury, and apoptosis/autophagy transitions (source: Cheng et al., 2026). It is insoluble in water but soluble in ethanol and DMSO (source: product_spec). The compound is intended for research use only.

    Biological Rationale

    Calcium ions (Ca2+) are essential second messengers, regulating autophagy, apoptosis, and cellular stress responses. The endoplasmic reticulum (ER) is the main intracellular Ca2+ store, and IP3 receptors (IP3R) mediate the release of Ca2+ into the cytoplasm in response to a variety of signals. Aberrant Ca2+ signaling is implicated in diverse physiological and pathological processes, including oxidative stress and programmed cell death in both mammalian and insect systems (source: Cheng et al., 2026).

    2-APB provides a selective means to inhibit IP3R-mediated Ca2+ release, allowing researchers to dissect the contribution of this pathway to autophagy, apoptosis, and oxidative injury. For example, in the Bombyx mori starvation model, 2-APB suppresses ER Ca2+ efflux, autophagy, and apoptosis, demonstrating the centrality of Ca2+ dynamics in cell fate transitions (source: Cheng et al., 2026).

    Mechanism of Action of 2-APB (2-aminoethoxydiphenyl borate)

    2-APB acts as a small-molecule antagonist of IP3 receptors, blocking IP3-induced Ca2+ release from the ER. The compound binds to IP3R and prevents channel opening, effectively inhibiting downstream Ca2+ mobilization. In addition to direct IP3R antagonism, 2-APB also inhibits store-operated calcium entry (SOCE) and transient receptor potential canonical (TRPC) channels, including TRPC3, TRPC5, and TRPC6 (source: internal_interlink).

    In cell-based assays, 2-APB blocks both Ca2+ oscillations and waves, which are essential for signal transduction, cell survival, and stress adaptation (source: product_spec). By suppressing cytoplasmic Ca2+ increases, it enables precise study of Ca2+-dependent pathways such as the ER-Ca2+-calpain axis, which regulates the balance between autophagy and apoptosis (source: Cheng et al., 2026).

    Evidence & Benchmarks

    • 2-APB inhibits IP3-induced Ca2+ release in rat cerebellar microsomes with an IC50 of 42 μM (source: product_spec).
    • The compound blocks TRPC5-dependent Ca2+ entry in HEK-293 cells with an IC50 of 20 μM (source: workflow_recommendation).
    • In Bombyx mori fat body cells, 2-APB at 50 μM suppressed starvation-induced Ca2+ signaling, autophagy (LC3-II, ATG5 upregulation), and apoptosis (NtATG5, caspase-3 activation), demonstrating blockade of ER-Ca2+-calpain signaling (source: Cheng et al., 2026).
    • Intraperitoneal administration of 2-APB (2–4 mg/kg) in animal ischemia-reperfusion models increases superoxide dismutase and glutathione, and reduces DNA fragmentation, supporting its use in oxidative stress-related cell injury research (source: product_spec).
    • 2-APB is insoluble in water but soluble in ethanol (≥27.85 mg/mL) and DMSO (≥9.4 mg/mL), with solutions recommended for immediate use (source: product_spec).

    This article extends previous reviews by providing direct numeric benchmarks and cross-validating autophagy/apoptosis findings in insect models, unlike the broader mechanistic focus in Dissecting Calcium Signaling Pathways.

    For a detailed experimental design guide, see Optimizing Cell Fate Studies; this article updates those recommendations with recent in vivo and insect data.

    Applications, Limits & Misconceptions

    2-APB is widely adopted for:

    • Inhibition of IP3R-mediated intracellular Ca2+ release to dissect autophagy/apoptosis cross-talk (source: Cheng et al., 2026).
    • Blockade of store-operated calcium entry (SOCE) and TRPC channel activity in cell culture and ex vivo models (source: internal_interlink).
    • Modeling oxidative stress-related cell injury, including animal ischemia-reperfusion injury (source: product_spec).
    • Calcium oscillation and wave suppression in neurobiology and metabolism studies (source: workflow_recommendation).

    Common Pitfalls or Misconceptions

    • 2-APB is not a pan-calcium channel blocker; it is selective for IP3R and specific TRPC channels.
    • It is not suitable for long-term solution storage; instability may affect reproducibility.
    • Not recommended for diagnostic or therapeutic use; strictly for research applications (source: product_spec).
    • At high concentrations (>100 μM), off-target effects (including SOCE modulation) may confound interpretation.
    • Solubility constraints require careful solvent selection (not water-soluble).

    Workflow Integration & Parameters

    Protocol Parameters

    • IP3-induced Ca2+ release assay | IC50 = 42 μM | rat cerebellar microsomes | standard for IP3R inhibition | product_spec
    • TRPC5 channel inhibition | IC50 = 20 μM | HEK-293 cells | benchmark for TRPC channel studies | workflow_recommendation
    • Cell culture concentration | 10–100 μM | mammalian/insect cells | typical working range for acute experiments | workflow_recommendation
    • Animal dosing | 2–4 mg/kg, i.p. | rodent ischemia-reperfusion | oxidative stress modulation | product_spec
    • Solvent | DMSO (≥9.4 mg/mL), ethanol (≥27.85 mg/mL) | solution prep | for optimal solubility and delivery | product_spec
    • Solution stability | immediate use recommended | all applications | prevents compound degradation | product_spec

    Conclusion & Outlook

    2-APB (2-aminoethoxydiphenyl borate), supplied by APExBIO as the B6643 kit, is a validated, high-precision IP3R antagonist enabling targeted modulation of intracellular Ca2+ signaling. Its selective action on IP3R and TRPC channels supports research into autophagy, apoptosis, and oxidative cell injury across multiple model systems (source: Cheng et al., 2026). The compound’s documented solubility characteristics and dose benchmarks facilitate reproducible experimental design. Researchers should remain aware of off-target effects at high concentrations and solubility limitations. As calcium signaling research evolves, 2-APB remains central for dissecting the mechanistic underpinnings of cell fate decisions (source: internal_interlink).

    For product specifications and ordering, see APExBIO’s 2-APB (2-aminoethoxydiphenyl borate).